Plasma-based approach to measure target engagement for liver-targeting stearoyl-CoA desaturase 1 inhibitors

A positive correlation between stearoyl-CoA desaturase (SCD)1 expression and metabolic diseases has been reported in rodents and humans. These findings indicate that SCD1 is a promising therapeutic target for the chronic treatment of diabetes and dyslipidemia. The SCD1 enzyme is expressed at high le...

Full description

Bibliographic Details
Main Authors: France Landry, Chi-Chung Chan, Zheng Huang, Gregoire Leclair, Chun Sing Li, Renata Oballa, Lei Zhang, Kevin Bateman
Format: Article
Language:English
Published: Elsevier 2011-08-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520369248